Compile Data Set for Download or QSAR
Report error Found 18 Enz. Inhib. hit(s) with all data for entry = 50015923
TargetGTPase KRas(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50590536(CHEMBL5209329)
Affinity DataIC50: 70nMAssay Description:Inhibition of biotinylated Avi-tagged GDP-bound KRAS G12C mutant (1 to 185 residues) (unknown origin) assessed as inhibition of KRAS G12C mutant/SOS/...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
PubMed
TargetGTPase KRas(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50590537(CHEMBL5205152)
Affinity DataIC50: 77nMAssay Description:Inhibition of biotinylated Avi-tagged GDP-bound KRAS G12C mutant (1 to 185 residues) (unknown origin) assessed as inhibition of KRAS G12C mutant/SOS/...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
PubMed
TargetGTPase KRas(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50590541(CHEMBL5181467)
Affinity DataIC50: 130nMAssay Description:Inhibition of biotinylated Avi-tagged GDP-bound KRAS G12C mutant (1 to 185 residues) (unknown origin) assessed as inhibition of KRAS G12C mutant/SOS/...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
PubMed
TargetGTPase KRas(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50590532(CHEMBL5208546)
Affinity DataIC50: 160nMAssay Description:Inhibition of biotinylated Avi-tagged GDP-bound KRAS G12C mutant (1 to 185 residues) (unknown origin) assessed as inhibition of KRAS G12C mutant/SOS/...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
PubMed
TargetGTPase KRas(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50590543(CHEMBL5186010)
Affinity DataIC50: 260nMAssay Description:Inhibition of biotinylated Avi-tagged GDP-bound KRAS G12C mutant (1 to 185 residues) (unknown origin) assessed as inhibition of KRAS G12C mutant/SOS/...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
PubMed
TargetGTPase KRas(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50590542(CHEMBL5191000)
Affinity DataIC50: 340nMAssay Description:Inhibition of biotinylated Avi-tagged GDP-bound KRAS G12C mutant (1 to 185 residues) (unknown origin) assessed as inhibition of KRAS G12C mutant/SOS/...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
PubMed
TargetGTPase KRas(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50590533(CHEMBL5204061)
Affinity DataIC50: 350nMAssay Description:Inhibition of biotinylated Avi-tagged GDP-bound KRAS G12C mutant (1 to 185 residues) (unknown origin) assessed as inhibition of KRAS G12C mutant/SOS/...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
PubMed
TargetGTPase KRas(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50590545(CHEMBL5206689)
Affinity DataIC50: 370nMAssay Description:Inhibition of biotinylated Avi-tagged GDP-bound KRAS G12C mutant (1 to 185 residues) (unknown origin) assessed as inhibition of KRAS G12C mutant/SOS/...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
PubMed
TargetGTPase KRas(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50590530(CHEMBL5196734)
Affinity DataIC50: 470nMAssay Description:Inhibition of biotinylated Avi-tagged GDP-bound KRAS G12C mutant (1 to 185 residues) (unknown origin) assessed as inhibition of KRAS G12C mutant/SOS/...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
PubMed
TargetGTPase KRas(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50590546(CHEMBL5177793)
Affinity DataIC50: 650nMAssay Description:Inhibition of biotinylated Avi-tagged GDP-bound KRAS G12C mutant (1 to 185 residues) (unknown origin) assessed as inhibition of KRAS G12C mutant/SOS/...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
PubMed
TargetGTPase KRas(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50590544(CHEMBL5196761)
Affinity DataIC50: 770nMAssay Description:Inhibition of biotinylated Avi-tagged GDP-bound KRAS G12C mutant (1 to 185 residues) (unknown origin) assessed as inhibition of KRAS G12C mutant/SOS/...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
PubMed
TargetGTPase KRas(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50590538(CHEMBL5181293)
Affinity DataIC50: 940nMAssay Description:Inhibition of biotinylated Avi-tagged GDP-bound KRAS G12C mutant (1 to 185 residues) (unknown origin) assessed as inhibition of KRAS G12C mutant/SOS/...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
PubMed
TargetGTPase KRas(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50590547(CHEMBL5202742)
Affinity DataIC50: 2.10E+3nMAssay Description:Inhibition of biotinylated Avi-tagged GDP-bound KRAS G12C mutant (1 to 185 residues) (unknown origin) assessed as inhibition of KRAS G12C mutant/SOS/...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
PubMed
TargetGTPase KRas(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50590531(CHEMBL5199429)
Affinity DataIC50: 3.00E+3nMAssay Description:Inhibition of biotinylated Avi-tagged GDP-bound KRAS G12C mutant (1 to 185 residues) (unknown origin) assessed as inhibition of KRAS G12C mutant/SOS/...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
PubMed
TargetGTPase KRas(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50590539(CHEMBL5187482)
Affinity DataIC50: 3.20E+3nMAssay Description:Inhibition of biotinylated Avi-tagged GDP-bound KRAS G12C mutant (1 to 185 residues) (unknown origin) assessed as inhibition of KRAS G12C mutant/SOS/...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
PubMed
TargetGTPase KRas(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50590540(CHEMBL5193630)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of biotinylated Avi-tagged GDP-bound KRAS G12C mutant (1 to 185 residues) (unknown origin) assessed as inhibition of KRAS G12C mutant/SOS/...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
PubMed
TargetGTPase KRas(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50590534(CHEMBL5208763)
Affinity DataIC50: 1.80E+4nMAssay Description:Inhibition of biotinylated Avi-tagged GDP-bound KRAS G12C mutant (1 to 185 residues) (unknown origin) assessed as inhibition of KRAS G12C mutant/SOS/...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
PubMed
TargetGTPase KRas(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50590535(CHEMBL5170321)
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of biotinylated Avi-tagged GDP-bound KRAS G12C mutant (1 to 185 residues) (unknown origin) assessed as inhibition of KRAS G12C mutant/SOS/...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
PubMed